For managed care organizations and health systems, the recommendations strongly advocated highly selective use of NGS. Routine, nonselective NGS for all sarcoma patients is not justified. Instead, ...
Pillar Biosciences, Inc., the leader in Decision Medicine™, has announced the launch of oncoReveal® Lymphoid, a ...
IDT and Beckman Coulter Life Sciences' collaboration marks a significant step forward in enabling labs to streamline oncology research workflows with enhanced precision, scalability, and ...
Request To Download Free Sample of This Strategic Report @ Market Overview: The global immuno-oncology assay market was valued at $2,769.50 million in 2018, and it is projected to reach $6,179.20 ...
This insightful review explores key areas of cancer genetic research, focusing on genes that may benefit from single-chromosome sequencing ...
Melanoma remains one of the hardest skin cancers to diagnose because it often mimics harmless moles or lesions. While most ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback